Clinical trial
Efficacy of Artificial Intelligence Aid-digital Single-operator Cholangioscopy (DSOC) Guided-biopsy Sampling in Suspected Cholangiocarcinoma: A Prospective, Randomized Trial
NCT05374122 is registered in ClinicalTrials.gov with Instituto Ecuatoriano de Enfermedades Digestivas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Artificial Intelligence Aid-digital Single-operator Cholangioscopy (DSOC) Guided-biopsy Sampling in Suspected Cholangiocarcinoma: A Prospective, Randomized Trial
- Lead sponsor
- Instituto Ecuatoriano de Enfermedades Digestivas
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 1, 2022
- Completion date
- May 1, 2024
- Enrollment
- 48 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bile duct lesions, bile duct neoplasms, neoplasms, non-neoplastic